Doxorubicin Completed Phase 3 Trials for Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00075725Dexamethasone Compared With Prednisone During Induction Therapy and MTX With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
NCT00002744Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00002812Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
NCT00004218Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
NCT00005945Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
NCT00005603Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00430118Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00613457Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia